Recombinant Cell Culture Supplements: Worldwide Market Analysis & Outlook (2018-2028) - Rising Demand for Monoclonal Antibodies and Stem Cell Research
DUBLIN, Dec 13, 2018 /PRNewswire/ --
The "Global Recombinant Cell Culture Supplements Market: Focus on Recombinant Supplement Products, Applications, and Region - Analysis and Forecast: 2018 to 2028" report has been added to ResearchAndMarkets.com's offering.
The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.
The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors supporting the growth of the market include increasing investment in the R&D of life sciences and biotechnology industries.
The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market, and scientific innovations into biotechnology and cell culture fields.
The scope of the report is centered upon conducting a detailed study of the solutions allied with the recombinant cell culture supplements market, involving products used for different applications such as bioproduction, research and academics, and stem cell and regenerative medicine. The global recombinant cell culture supplements market is segmented into three different parts: by products, by application, and by region.
Based on applications, the market can be sub-segmented into stem cell and regenerative medicine, bioproduction, and academic and research. In 2017, stem cell and regenerative medicine was estimated to be the dominant application segment due to the increased demand for investment in the stem cell and regenerative medicine industry in developed as well as developing nations.
However, the academic and research industry is expected to register the highest CAGR due to the rising investments and increased regulatory support for this industry. As recombinant supplements ensure enhanced cell viability and improved batch-to-batch consistency, they are increasingly used for research.
The recombinant cell culture supplements market can be further segmented based on the type of recombinant products into transferrin, insulin, albumin, trypsin, aprotinin, lysozyme, Insulin-like growth factor, stem cell factor, epidermal growth factor, and others. Recombinant albumin was the dominant segment in terms of revenue in 2017 while recombinant epidermal growth factor (rEGF) segment is expected to be the fastest growing segment during the forecast period from 2018 to 2028.
Geographically, the market is segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World. North America, followed by Europe, is the leading contributor of the market.
Within North America, the U.S. contributed to almost 93% of the total share, and the rest of the share was occupied by Canada in 2017. Within Europe, Germany dominated the market in 2017. However, the market for the Asia-Pacific region is expected to witness the high growth rate, during the forecast period from 2018 to 2028, as compared to other regions.
The recombinant cell culture supplements market has a promising potential for the growth in the coming years with the increased usage of cell cultures and biotechnology in the modern day science. The report provides an in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each company.
The key players of the market are Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incoporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.
Key Topics Covered
Executive Summary
1 Market Overview
1.1 Fundamentals of Cell Culture
1.2 Role of Media and Supplements
1.3 Serum-free Media vs. Serum containing Media
1.4 Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
1.5 Recombinant Cell Culture Supplements Market Scenario
1.6 Assumptions and Limitations for Market Size Calculations
2 Market Dynamics
2.1 Market Drivers
2.1.1 Benefits of Using Recombinant Cell Culture Supplements
2.1.2 Increase in Funding and Investment in R&D of Life Science Sector
2.1.3 Rising Demand for Advanced Cell Culture Products
2.2 Market Restraints
2.2.1 High Cost of Cell Biology Research
2.2.2 Technical Considerations Associated with Cell Culture
2.2.3 Lack of Infrastructure and Skilled Professionals for Cell-based Research
2.3 Market Opportunities
2.3.1 Rising Demand for Monoclonal Antibodies and Stem Cell Research
2.3.2 Increasing Preference for Serum-Free Media
3 Industry Insights
3.1 Regulatory Scenario
3.2 Patent Landscape
4 Competitive Landscape
4.1 Key Developmental Strategies
4.1.1 Product Launch
4.1.2 Agreement, Collaboration, and Partnership
4.1.3 Acquisition
4.1.4 Business Expansion
4.1.5 Others
4.2 Market Share Analysis
5 Global Recombinant Cell Culture Supplements Market (by Products)
5.1 Overview
5.2 Supplements
5.2.1 Recombinant Albumin (rAlbumin)
5.2.2 Recombinant Insulin (rInsulin)
5.2.3 Recombinant Epidermal Growth Factor (rEGF)
5.2.4 Recombinant Transferrin (rTransferrin)
5.2.5 Recombinant Trypsin (rTrypsin)
5.2.6 Recombinant Insulin-like Growth Factor (rIGF)
5.2.7 Recombinant Stem Cell Factor (SCF) Protein (rSCF)
5.2.8 Recombinant Aprotinin (rAprotinin)
5.2.9 Recombinant Lysozyme (rLysozyme)
5.2.10 Others
6 Global Recombinant Cell Culture Supplements Market (by Application)
6.1 Overview
6.2 Stem Cell and Regenerative Medicine
6.3 BioProduction
6.4 Academic and Research Application
7 Global Recombinant Cell Culture Supplements Market (by Region)
7.1 Overview
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Latin-America
7.6 Rest of the World (RoW)
8 Company Profiles
8.1 BBI Solutions
8.2 Corning Incorporated
8.3 Evercyte GmbH
8.4 Gemini Bio-Products
8.5 HiMedia Laboratories
8.6 InVitria
8.7 Irvine Scientific
8.8 Kingfisher Biotech, Inc.
8.9 Lonza Group
8.10 Merck KGaA
8.11 Novozymes
8.12 PeproTech, Inc.
8.13 Repligen Corporation
8.14 Shenandoah Biotechnology
8.15 Sino Biological Inc.
8.16 STEMCELL Technologies Inc.
8.17 Thermo Fisher Scientific
8.18 Albumedix: Snapshot
For more information about this report visit https://www.researchandmarkets.com/research/zp6sq7/recombinant_cell?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article